Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ayers

Showing results (191-200 of 225) with videos related to

Pageof 23
Sort By:
Plos One|September 26, 2024
Shared fate was associated with sustained cooperation during the COVID-19 pandemicDiego Guevara Beltran, Jessica D Ayers, Scott Claessens, et al.
Journal of Pediatric Surgery|July 13, 2013
Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapyAndrew J Murphy, Gregory D Ayers, Melissa A Hilmes, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growthJ Yang, K Bergdorf, C Yan, et al.
Heart Rhythm|October 18, 2023
Life-threatening cardiac arrhythmia and sudden death during electronic gaming: An international case series and systematic reviewClaire M Lawley, Matthew Tester, Shubhayan Sanatani, et al.
Ebiomedicine|October 15, 2017
MDM2 Antagonists Counteract Drug-Induced DNA DamageAnna E Vilgelm, Priscilla Cobb, Kiran Malikayil, et al.
Cancer Discovery|September 7, 2018
A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous LeukemiaHaley E Ramsey, Melissa A Fischer, Taekyu Lee, et al.
Blood|June 14, 2000
Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalitiesR Desikan, B Barlogie, J Sawyer, et al.
The Oncologist|December 3, 2025
NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancerMargaret C Wheless, Shannon Stockton, Heloisa P Soares, et al.
Molecular Cancer|June 3, 2023
CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growthJ Yang, K Bergdorf, C Yan, et al.
Cancer Immunology Research|March 5, 2015
Impact of NRAS mutations for patients with advanced melanoma treated with immune therapiesDouglas B Johnson, Christine M Lovly, Marisa Flavin, et al.
Pageof 23

Showing results (191-200 of 225) with videos related to

Sort By:
Pageof 23
Plos One|September 26, 2024
Shared fate was associated with sustained cooperation during the COVID-19 pandemicDiego Guevara Beltran, Jessica D Ayers, Scott Claessens, et al.
Journal of Pediatric Surgery|July 13, 2013
Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapyAndrew J Murphy, Gregory D Ayers, Melissa A Hilmes, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growthJ Yang, K Bergdorf, C Yan, et al.
Heart Rhythm|October 18, 2023
Life-threatening cardiac arrhythmia and sudden death during electronic gaming: An international case series and systematic reviewClaire M Lawley, Matthew Tester, Shubhayan Sanatani, et al.
Ebiomedicine|October 15, 2017
MDM2 Antagonists Counteract Drug-Induced DNA DamageAnna E Vilgelm, Priscilla Cobb, Kiran Malikayil, et al.
Cancer Discovery|September 7, 2018
A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous LeukemiaHaley E Ramsey, Melissa A Fischer, Taekyu Lee, et al.
Blood|June 14, 2000
Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalitiesR Desikan, B Barlogie, J Sawyer, et al.
The Oncologist|December 3, 2025
NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancerMargaret C Wheless, Shannon Stockton, Heloisa P Soares, et al.
Molecular Cancer|June 3, 2023
CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growthJ Yang, K Bergdorf, C Yan, et al.
Cancer Immunology Research|March 5, 2015
Impact of NRAS mutations for patients with advanced melanoma treated with immune therapiesDouglas B Johnson, Christine M Lovly, Marisa Flavin, et al.
Pageof 23